Almirall, S.A. is a Spanish pharmaceutical company, with headquarters in Barcelona, founded in 1943.

In 2016, it generated total revenue of 859.3 million € and became the leading pharmaceutical company in R&D investment in Spain.

With over 1,975 employees (2016), it has a presence, through its 13 affiliates in Europe and United States.

Activities

Almirall collaborates with various public and private entities, such as the Centro Superior de Investigaciones Científicas (CSIC), the Instituto de Investigación Biomédica and the Parc Científic de Barcelona in Spain. Highlighted among the international alliances are those with the Imperial College London (United Kingdom) and the National Institute of Health (NIH) in the United States. Almirall participated in the creation of the Barcelona Respiratory Network Foundation. In Europe, the company has contributed in several projects with the Innovative Medicines Initiative (IMI).